Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada

NCT01415401 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension
Open-angle Glaucoma

Interventions

DRUG: Brinzolamide 1% / timolol 0.5% maleate fixed combination

Sponsor

Alcon Research